Literature DB >> 20439821

Angiotensin II-induced vascular smooth muscle cell migration and growth are mediated by cytochrome P450 1B1-dependent superoxide generation.

Fariborz A Yaghini1, Chi Young Song, Eduard N Lavrentyev, Hafiz U B Ghafoor, Xiao R Fang, Anne M Estes, William B Campbell, Kafait U Malik.   

Abstract

Cytochrome P450 1B1, expressed in vascular smooth muscle cells, can metabolize arachidonic acid in vitro into several products including 12- and 20-hydroxyeicosatetraenoic acids that stimulate vascular smooth muscle cell growth. This study was conducted to determine whether cytochrome P450 1B1 contributes to angiotensin II-induced rat aortic smooth muscle cell migration, proliferation, and protein synthesis. Angiotensin II stimulated migration of these cells, measured by the wound healing approach, by 1.78-fold; and DNA synthesis, measured by [(3)H]thymidine incorporation, by 1.44-fold after 24 hours; and protein synthesis, measured by [(3)H]leucine incorporation, by 1.40-fold after 48 hours. Treatment of vascular smooth muscle cells with the cytochrome P450 1B1 inhibitor 2,4,3',5'-tetramethoxystilbene or transduction of these cells with adenovirus cytochrome P450 1B1 small hairpin RNA but not its scrambled control reduced the activity of this enzyme and abolished angiotensin II- and arachidonic acid-induced cell migration, as well as [(3)H]thymidine and [(3)H]leucine incorporation. Metabolism of arachidonic acid to 5-, 12-, 15-, and 20-hydoxyeicosatetraenoic acids in these cells was not altered, but angiotensin II- and arachidonic acid-induced reactive oxygen species production and extracellular signal-regulated kinase 1/2 and p38 mitogen-activated protein kinase activity were inhibited by 2,4,3',5'-tetramethoxystilbene and cytochrome P450 1B1 small hairpin RNA (shRNA) and by Tempol, which inactivates reactive oxygen species. Tempol did not alter cytochrome P450 1B1 activity. These data suggest that angiotensin II-induced vascular smooth muscle cell migration and growth are mediated by reactive oxygen species generated from arachidonic acid by cytochrome P450 1B1 and activation of extracellular signal-regulated kinase 1/2 and p38 mitogen-activated protein kinase.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20439821      PMCID: PMC2916227          DOI: 10.1161/HYPERTENSIONAHA.110.150029

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  44 in total

Review 1.  Arachidonic Acid metabolites in the cardiovascular system: the role of lipoxygenase isoforms in atherogenesis with particular emphasis on vascular remodeling.

Authors:  Hartmut Kuhn; Pavlos Chaitidis; Jana Roffeis; Matthias Walther
Journal:  J Cardiovasc Pharmacol       Date:  2007-12       Impact factor: 3.105

2.  Reactive oxygen species from the uncoupling of human cytochrome P450 1B1 may contribute to the carcinogenicity of dioxin-like polychlorinated biphenyls.

Authors:  Richard M Green; Nikolas J Hodges; J Kevin Chipman; Michael R O'Donovan; Mark Graham
Journal:  Mutagenesis       Date:  2008-06-26       Impact factor: 3.000

Review 3.  Reactive oxygen species as mediators of angiotensin II signaling.

Authors:  K K Griendling; M Ushio-Fukai
Journal:  Regul Pept       Date:  2000-07-28

4.  Contribution of arachidonic acid metabolites derived via cytochrome P4504A to angiotensin II-induced neointimal growth.

Authors:  Fariborz A Yaghini; Chunxiang Zhang; Jean-Hugues Parmentier; Anne M Estes; Nauzanene Jafari; Susan A Schaefer; Kafait U Malik
Journal:  Hypertension       Date:  2005-05-16       Impact factor: 10.190

5.  20-Hydroxyeicosatetraenoic acid (20-HETE) stimulates migration of vascular smooth muscle cells.

Authors:  David E Stec; Kimberly P Gannon; Janis S Beaird; Heather A Drummond
Journal:  Cell Physiol Biochem       Date:  2007

Review 6.  The intrarenal renin-angiotensin system: from physiology to the pathobiology of hypertension and kidney disease.

Authors:  Hiroyuki Kobori; Masaomi Nangaku; L Gabriel Navar; Akira Nishiyama
Journal:  Pharmacol Rev       Date:  2007-09       Impact factor: 25.468

Review 7.  Roles of the cytochrome P450 arachidonic acid monooxygenases in the control of systemic blood pressure and experimental hypertension.

Authors:  J H Capdevila; J R Falck; J D Imig
Journal:  Kidney Int       Date:  2007-06-27       Impact factor: 10.612

8.  Expression of CYP1A1 and CYP1B1 in human endothelial cells: regulation by fluid shear stress.

Authors:  Daniel E Conway; Yumiko Sakurai; Daiana Weiss; J David Vega; W Robert Taylor; Hanjoong Jo; Suzanne G Eskin; Craig B Marcus; Larry V McIntire
Journal:  Cardiovasc Res       Date:  2009-01-06       Impact factor: 10.787

Review 9.  Chemistry and antihypertensive effects of tempol and other nitroxides.

Authors:  Christopher S Wilcox; Adam Pearlman
Journal:  Pharmacol Rev       Date:  2008-12       Impact factor: 25.468

10.  CYP1B1 expression promotes the proangiogenic phenotype of endothelium through decreased intracellular oxidative stress and thrombospondin-2 expression.

Authors:  Yixin Tang; Elizabeth A Scheef; Shoujian Wang; Christine M Sorenson; Craig B Marcus; Colin R Jefcoate; Nader Sheibani
Journal:  Blood       Date:  2008-11-12       Impact factor: 22.113

View more
  39 in total

1.  Response gene to complement 32 promotes vascular lesion formation through stimulation of smooth muscle cell proliferation and migration.

Authors:  Jia-Ning Wang; Ning Shi; Wei-Bing Xie; Xia Guo; Shi-You Chen
Journal:  Arterioscler Thromb Vasc Biol       Date:  2011-06-02       Impact factor: 8.311

Review 2.  Cell signaling of angiotensin II on vascular tone: novel mechanisms.

Authors:  Aurelie Nguyen Dinh Cat; Rhian M Touyz
Journal:  Curr Hypertens Rep       Date:  2011-04       Impact factor: 5.369

3.  Manganese superoxide dismutase inhibits neointima formation through attenuation of migration and proliferation of vascular smooth muscle cells.

Authors:  Jia-Ning Wang; Ning Shi; Shi-You Chen
Journal:  Free Radic Biol Med       Date:  2011-10-24       Impact factor: 7.376

4.  Cytosolic phospholipase A2α is critical for angiotensin II-induced hypertension and associated cardiovascular pathophysiology.

Authors:  Nayaab S Khan; Chi Young Song; Brett L Jennings; Anne M Estes; Xiao R Fang; Joseph V Bonventre; Kafait U Malik
Journal:  Hypertension       Date:  2015-02-09       Impact factor: 10.190

Review 5.  Biological roles of cytochrome P450 1A1, 1A2, and 1B1 enzymes.

Authors:  Yeo-Jung Kwon; Sangyun Shin; Young-Jin Chun
Journal:  Arch Pharm Res       Date:  2021-01-23       Impact factor: 4.946

6.  Cytosolic Phospholipase A2α Is Essential for Renal Dysfunction and End-Organ Damage Associated With Angiotensin II-Induced Hypertension.

Authors:  Nayaab S Khan; Chi Young Song; Shyamala Thirunavukkarasu; Xiao R Fang; Joseph V Bonventre; Kafait U Malik
Journal:  Am J Hypertens       Date:  2015-06-04       Impact factor: 2.689

7.  Vascular smooth muscle cell motility: From migration to invasion.

Authors:  Sherif F Louis; Peter Zahradka
Journal:  Exp Clin Cardiol       Date:  2010

Review 8.  The biological significance of angiotensin-converting enzyme inhibition to combat kidney fibrosis.

Authors:  Takako Nagai; Kyoko Nitta; Megumi Kanasaki; Daisuke Koya; Keizo Kanasaki
Journal:  Clin Exp Nephrol       Date:  2014-07-01       Impact factor: 2.801

Review 9.  Contribution of cytochrome P450 1B1 to hypertension and associated pathophysiology: a novel target for antihypertensive agents.

Authors:  Kafait U Malik; Brett L Jennings; Fariborz A Yaghini; Seyhan Sahan-Firat; Chi Young Song; Anne M Estes; Xiao R Fang
Journal:  Prostaglandins Other Lipid Mediat       Date:  2011-12-20       Impact factor: 3.072

10.  Inhibition of angiotensin II-induced cerebrovascular smooth muscle cell proliferation by LRRC8A downregulation through suppressing PI3K/AKT activation.

Authors:  Jingjing Lu; Feng Xu; Jiewen Zhang
Journal:  Hum Cell       Date:  2019-05-24       Impact factor: 4.174

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.